|
|
|
|
|
|
|
|
|
|
|
29.05.25 - 14:03
|
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference (GlobeNewswire EN)
|
|
|
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 2:35 p.m. ET....
|
|
|
|
|
|
|
13.05.25 - 10:00
|
CytomX-Aktie +130%: Top-Tipp knallt, nächster Zahltag! (Sharedeals)
|
|
|
Wenn es eine Aktie gibt, die immer wieder für Jubelstürme in der Community von sharedealsPLUS sorgt, dann ist es die des Biotech-Unternehmens CytomX. Schon mehrfach gab es aus dem Nichts Kursexplosionen, am gestrigen Montag die nächste, denn der Titel schoss um +130% auf 2,13 US$ hoch. Was steckt diesmal dahinter und wie geht es weiter? […]
The post CytomX-Aktie +130%: Top-Tipp knallt, nächster Zahltag! first appeared on sharedeals.de....
|
|
|
|
|
|
|
12.05.25 - 12:54
|
CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock (GlobeNewswire EN)
|
|
|
SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced the pricing of an underwritten offering of 76,923,076 shares of its common stock at an offering price of $1.30 per share, before underwriting discounts and commissions. All of the shares are being offered by the Company. The gross proceeds from the offering are expected to be approximately $100 million before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on May 13, 2025, subject to customary closing conditions....
|
|
|
|
|
|
|
|
|
|
|
05.05.25 - 14:03
|
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025 (GlobeNewswire EN)
|
|
|
SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that it will report first quarter financial results on Monday, May 12, 2025, before the open of the U.S. markets. Following the announcement, the Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT....
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
